Barclays »

Capstone Therapeutics Corporat shares owned by Barclays

Quarter-by-quarter ownership of Capstone Therapeutics Corporat (CAPS) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Capstone Therapeutics Corporat

Tip: Access up to 7 years of quarterly data

All positions including Capstone Therapeutics Corporat held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capstone Therapeutics Corporat by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $285 1.1k 0.25

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Capstone Therapeutics Corporat

Geode Capital Management
Jane Street
Intl Fcstone
Hrt Financial
Goldman Sachs Group
Northern Trust
Ground Swell Capital
Barclays
KERR FINANCIAL PLANNING Corp
Citigroup
Morgan Stanley

View all funds holding Capstone Therapeutics Corporat